THANOCRINE
associated with 11 other trademarks
Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurologic...

Words that describe this trademark:

diseases immune  cellular signal  treating cancer  signal modulation  pharmaceutical  cancer  products  agents  modulation  fibrotic 

Serial Number:

90379452

Mark:

THANOCRINE

Status:

Abandoned-No Statement of Use filed

Status Date:

01-30-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

11-02-2021

Mark Drawing Status:

Standart Character Mark

Abandon Date:

01-30-2023

Business Name:

WOLF, GREENFIELD & SACKS, P.C.

Correspondent Name:

Recent Trademark filings by this company